Human neutralizing antibodies to cold linear epitopes and subdomain 1 of the SARS-CoV-2 spike glycoprotein. 2023

Filippo Bianchini, and Virginia Crivelli, and Morgan E Abernathy, and Concetta Guerra, and Martin Palus, and Jonathan Muri, and Harold Marcotte, and Antonio Piralla, and Mattia Pedotti, and Raoul De Gasparo, and Luca Simonelli, and Milos Matkovic, and Chiara Toscano, and Maira Biggiogero, and Veronica Calvaruso, and Pavel Svoboda, and Tomás Cervantes Rincón, and Tommaso Fava, and Lucie Podešvová, and Akanksha A Shanbhag, and Andrea Celoria, and Jacopo Sgrignani, and Michal Stefanik, and Vaclav Hönig, and Veronika Pranclova, and Tereza Michalcikova, and Jan Prochazka, and Giuditta Guerrini, and Dora Mehn, and Annalisa Ciabattini, and Hassan Abolhassani, and David Jarrossay, and Mariagrazia Uguccioni, and Donata Medaglini, and Qiang Pan-Hammarström, and Luigi Calzolai, and Daniel Fernandez, and Fausto Baldanti, and Alessandra Franzetti-Pellanda, and Christian Garzoni, and Radislav Sedlacek, and Daniel Ruzek, and Luca Varani, and Andrea Cavalli, and Christopher O Barnes, and Davide F Robbiani
Institute for Research in Biomedicine, Università della Svizzera italiana, Bellinzona, Switzerland.

Emergence of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) variants diminishes the efficacy of vaccines and antiviral monoclonal antibodies. Continued development of immunotherapies and vaccine immunogens resilient to viral evolution is therefore necessary. Using coldspot-guided antibody discovery, a screening approach that focuses on portions of the virus spike glycoprotein that are both functionally relevant and averse to change, we identified human neutralizing antibodies to highly conserved viral epitopes. Antibody fp.006 binds the fusion peptide and cross-reacts against coronaviruses of the four genera, including the nine human coronaviruses, through recognition of a conserved motif that includes the S2' site of proteolytic cleavage. Antibody hr2.016 targets the stem helix and neutralizes SARS-CoV-2 variants. Antibody sd1.040 binds to subdomain 1, synergizes with antibody rbd.042 for neutralization, and, similar to fp.006 and hr2.016, protects mice expressing human angiotensin-converting enzyme 2 against infection when present as a bispecific antibody. Thus, coldspot-guided antibody discovery reveals donor-derived neutralizing antibodies that are cross-reactive with Orthocoronavirinae, including SARS-CoV-2 variants.

UI MeSH Term Description Entries
D009500 Neutralization Tests The measurement of infection-blocking titer of ANTISERA by testing a series of dilutions for a given virus-antiserum interaction end-point, which is generally the dilution at which tissue cultures inoculated with the serum-virus mixtures demonstrate cytopathology (CPE) or the dilution at which 50% of test animals injected with serum-virus mixtures show infectivity (ID50) or die (LD50). Neutralization Test,Test, Neutralization,Tests, Neutralization
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000086382 COVID-19 A viral disorder generally characterized by high FEVER; COUGH; DYSPNEA; CHILLS; PERSISTENT TREMOR; MUSCLE PAIN; HEADACHE; SORE THROAT; a new loss of taste and/or smell (see AGEUSIA and ANOSMIA) and other symptoms of a VIRAL PNEUMONIA. In severe cases, a myriad of coagulopathy associated symptoms often correlating with COVID-19 severity is seen (e.g., BLOOD COAGULATION; THROMBOSIS; ACUTE RESPIRATORY DISTRESS SYNDROME; SEIZURES; HEART ATTACK; STROKE; multiple CEREBRAL INFARCTIONS; KIDNEY FAILURE; catastrophic ANTIPHOSPHOLIPID ANTIBODY SYNDROME and/or DISSEMINATED INTRAVASCULAR COAGULATION). In younger patients, rare inflammatory syndromes are sometimes associated with COVID-19 (e.g., atypical KAWASAKI SYNDROME; TOXIC SHOCK SYNDROME; pediatric multisystem inflammatory disease; and CYTOKINE STORM SYNDROME). A coronavirus, SARS-CoV-2, in the genus BETACORONAVIRUS is the causative agent. 2019 Novel Coronavirus Disease,2019 Novel Coronavirus Infection,2019-nCoV Disease,2019-nCoV Infection,COVID-19 Pandemic,COVID-19 Pandemics,COVID-19 Virus Disease,COVID-19 Virus Infection,Coronavirus Disease 2019,Coronavirus Disease-19,SARS Coronavirus 2 Infection,SARS-CoV-2 Infection,Severe Acute Respiratory Syndrome Coronavirus 2 Infection,COVID19,2019 nCoV Disease,2019 nCoV Infection,2019-nCoV Diseases,2019-nCoV Infections,COVID 19,COVID 19 Pandemic,COVID 19 Virus Disease,COVID 19 Virus Infection,COVID-19 Virus Diseases,COVID-19 Virus Infections,Coronavirus Disease 19,Disease 2019, Coronavirus,Disease, 2019-nCoV,Disease, COVID-19 Virus,Infection, 2019-nCoV,Infection, COVID-19 Virus,Infection, SARS-CoV-2,Pandemic, COVID-19,SARS CoV 2 Infection,SARS-CoV-2 Infections,Virus Disease, COVID-19,Virus Infection, COVID-19
D000086402 SARS-CoV-2 A species of BETACORONAVIRUS causing atypical respiratory disease (COVID-19) in humans. The organism was first identified in 2019 in Wuhan, China. The natural host is the Chinese intermediate horseshoe bat, RHINOLOPHUS affinis. 2019 Novel Coronavirus,COVID-19 Virus,COVID19 Virus,Coronavirus Disease 2019 Virus,SARS Coronavirus 2,SARS-CoV-2 Virus,Severe Acute Respiratory Syndrome Coronavirus 2,Wuhan Coronavirus,Wuhan Seafood Market Pneumonia Virus,2019-nCoV,2019 Novel Coronaviruses,COVID 19 Virus,COVID-19 Viruses,COVID19 Viruses,Coronavirus 2, SARS,Coronavirus, 2019 Novel,Coronavirus, Wuhan,Novel Coronavirus, 2019,SARS CoV 2 Virus,SARS-CoV-2 Viruses,Virus, COVID-19,Virus, COVID19,Virus, SARS-CoV-2,Viruses, COVID19
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D000914 Antibodies, Viral Immunoglobulins produced in response to VIRAL ANTIGENS. Viral Antibodies
D000939 Epitopes Sites on an antigen that interact with specific antibodies. Antigenic Determinant,Antigenic Determinants,Antigenic Specificity,Epitope,Determinant, Antigenic,Determinants, Antigenic,Specificity, Antigenic
D051379 Mice The common name for the genus Mus. Mice, House,Mus,Mus musculus,Mice, Laboratory,Mouse,Mouse, House,Mouse, Laboratory,Mouse, Swiss,Mus domesticus,Mus musculus domesticus,Swiss Mice,House Mice,House Mouse,Laboratory Mice,Laboratory Mouse,Mice, Swiss,Swiss Mouse,domesticus, Mus musculus
D057134 Antibodies, Neutralizing Antibodies that reduce or abolish some biological activity of a soluble antigen or infectious agent, usually a virus. Neutralizing Antibodies,Antibody, Neutralizing,Neutralizing Antibody
D064370 Spike Glycoprotein, Coronavirus A class I viral fusion protein that forms the characteristic spikes, or peplomers, found on the viral surface that mediate virus attachment, fusion, and entry into the host cell. During virus maturation, it is cleaved into two subunits: S1, which binds to receptors in the host cell, and S2, which mediates membrane fusion. Spike Glycoprotein, Bovine Coronavirus,Spike Glycoproteins, Coronavirus,E2 Spike Glycoprotein, Coronavirus,Glycoprotein S, Coronavirus,Spike Glycoprotein S1, Coronavirus,Spike Protein S2, Coronavirus,Spike Protein, Coronavirus,Coronavirus Spike Glycoprotein,Coronavirus Spike Protein

Related Publications

Filippo Bianchini, and Virginia Crivelli, and Morgan E Abernathy, and Concetta Guerra, and Martin Palus, and Jonathan Muri, and Harold Marcotte, and Antonio Piralla, and Mattia Pedotti, and Raoul De Gasparo, and Luca Simonelli, and Milos Matkovic, and Chiara Toscano, and Maira Biggiogero, and Veronica Calvaruso, and Pavel Svoboda, and Tomás Cervantes Rincón, and Tommaso Fava, and Lucie Podešvová, and Akanksha A Shanbhag, and Andrea Celoria, and Jacopo Sgrignani, and Michal Stefanik, and Vaclav Hönig, and Veronika Pranclova, and Tereza Michalcikova, and Jan Prochazka, and Giuditta Guerrini, and Dora Mehn, and Annalisa Ciabattini, and Hassan Abolhassani, and David Jarrossay, and Mariagrazia Uguccioni, and Donata Medaglini, and Qiang Pan-Hammarström, and Luigi Calzolai, and Daniel Fernandez, and Fausto Baldanti, and Alessandra Franzetti-Pellanda, and Christian Garzoni, and Radislav Sedlacek, and Daniel Ruzek, and Luca Varani, and Andrea Cavalli, and Christopher O Barnes, and Davide F Robbiani
October 2020, Cellular & molecular immunology,
Filippo Bianchini, and Virginia Crivelli, and Morgan E Abernathy, and Concetta Guerra, and Martin Palus, and Jonathan Muri, and Harold Marcotte, and Antonio Piralla, and Mattia Pedotti, and Raoul De Gasparo, and Luca Simonelli, and Milos Matkovic, and Chiara Toscano, and Maira Biggiogero, and Veronica Calvaruso, and Pavel Svoboda, and Tomás Cervantes Rincón, and Tommaso Fava, and Lucie Podešvová, and Akanksha A Shanbhag, and Andrea Celoria, and Jacopo Sgrignani, and Michal Stefanik, and Vaclav Hönig, and Veronika Pranclova, and Tereza Michalcikova, and Jan Prochazka, and Giuditta Guerrini, and Dora Mehn, and Annalisa Ciabattini, and Hassan Abolhassani, and David Jarrossay, and Mariagrazia Uguccioni, and Donata Medaglini, and Qiang Pan-Hammarström, and Luigi Calzolai, and Daniel Fernandez, and Fausto Baldanti, and Alessandra Franzetti-Pellanda, and Christian Garzoni, and Radislav Sedlacek, and Daniel Ruzek, and Luca Varani, and Andrea Cavalli, and Christopher O Barnes, and Davide F Robbiani
July 2020, bioRxiv : the preprint server for biology,
Filippo Bianchini, and Virginia Crivelli, and Morgan E Abernathy, and Concetta Guerra, and Martin Palus, and Jonathan Muri, and Harold Marcotte, and Antonio Piralla, and Mattia Pedotti, and Raoul De Gasparo, and Luca Simonelli, and Milos Matkovic, and Chiara Toscano, and Maira Biggiogero, and Veronica Calvaruso, and Pavel Svoboda, and Tomás Cervantes Rincón, and Tommaso Fava, and Lucie Podešvová, and Akanksha A Shanbhag, and Andrea Celoria, and Jacopo Sgrignani, and Michal Stefanik, and Vaclav Hönig, and Veronika Pranclova, and Tereza Michalcikova, and Jan Prochazka, and Giuditta Guerrini, and Dora Mehn, and Annalisa Ciabattini, and Hassan Abolhassani, and David Jarrossay, and Mariagrazia Uguccioni, and Donata Medaglini, and Qiang Pan-Hammarström, and Luigi Calzolai, and Daniel Fernandez, and Fausto Baldanti, and Alessandra Franzetti-Pellanda, and Christian Garzoni, and Radislav Sedlacek, and Daniel Ruzek, and Luca Varani, and Andrea Cavalli, and Christopher O Barnes, and Davide F Robbiani
August 2020, Nature,
Filippo Bianchini, and Virginia Crivelli, and Morgan E Abernathy, and Concetta Guerra, and Martin Palus, and Jonathan Muri, and Harold Marcotte, and Antonio Piralla, and Mattia Pedotti, and Raoul De Gasparo, and Luca Simonelli, and Milos Matkovic, and Chiara Toscano, and Maira Biggiogero, and Veronica Calvaruso, and Pavel Svoboda, and Tomás Cervantes Rincón, and Tommaso Fava, and Lucie Podešvová, and Akanksha A Shanbhag, and Andrea Celoria, and Jacopo Sgrignani, and Michal Stefanik, and Vaclav Hönig, and Veronika Pranclova, and Tereza Michalcikova, and Jan Prochazka, and Giuditta Guerrini, and Dora Mehn, and Annalisa Ciabattini, and Hassan Abolhassani, and David Jarrossay, and Mariagrazia Uguccioni, and Donata Medaglini, and Qiang Pan-Hammarström, and Luigi Calzolai, and Daniel Fernandez, and Fausto Baldanti, and Alessandra Franzetti-Pellanda, and Christian Garzoni, and Radislav Sedlacek, and Daniel Ruzek, and Luca Varani, and Andrea Cavalli, and Christopher O Barnes, and Davide F Robbiani
August 2021, ACS pharmacology & translational science,
Filippo Bianchini, and Virginia Crivelli, and Morgan E Abernathy, and Concetta Guerra, and Martin Palus, and Jonathan Muri, and Harold Marcotte, and Antonio Piralla, and Mattia Pedotti, and Raoul De Gasparo, and Luca Simonelli, and Milos Matkovic, and Chiara Toscano, and Maira Biggiogero, and Veronica Calvaruso, and Pavel Svoboda, and Tomás Cervantes Rincón, and Tommaso Fava, and Lucie Podešvová, and Akanksha A Shanbhag, and Andrea Celoria, and Jacopo Sgrignani, and Michal Stefanik, and Vaclav Hönig, and Veronika Pranclova, and Tereza Michalcikova, and Jan Prochazka, and Giuditta Guerrini, and Dora Mehn, and Annalisa Ciabattini, and Hassan Abolhassani, and David Jarrossay, and Mariagrazia Uguccioni, and Donata Medaglini, and Qiang Pan-Hammarström, and Luigi Calzolai, and Daniel Fernandez, and Fausto Baldanti, and Alessandra Franzetti-Pellanda, and Christian Garzoni, and Radislav Sedlacek, and Daniel Ruzek, and Luca Varani, and Andrea Cavalli, and Christopher O Barnes, and Davide F Robbiani
December 2023, Emerging microbes & infections,
Filippo Bianchini, and Virginia Crivelli, and Morgan E Abernathy, and Concetta Guerra, and Martin Palus, and Jonathan Muri, and Harold Marcotte, and Antonio Piralla, and Mattia Pedotti, and Raoul De Gasparo, and Luca Simonelli, and Milos Matkovic, and Chiara Toscano, and Maira Biggiogero, and Veronica Calvaruso, and Pavel Svoboda, and Tomás Cervantes Rincón, and Tommaso Fava, and Lucie Podešvová, and Akanksha A Shanbhag, and Andrea Celoria, and Jacopo Sgrignani, and Michal Stefanik, and Vaclav Hönig, and Veronika Pranclova, and Tereza Michalcikova, and Jan Prochazka, and Giuditta Guerrini, and Dora Mehn, and Annalisa Ciabattini, and Hassan Abolhassani, and David Jarrossay, and Mariagrazia Uguccioni, and Donata Medaglini, and Qiang Pan-Hammarström, and Luigi Calzolai, and Daniel Fernandez, and Fausto Baldanti, and Alessandra Franzetti-Pellanda, and Christian Garzoni, and Radislav Sedlacek, and Daniel Ruzek, and Luca Varani, and Andrea Cavalli, and Christopher O Barnes, and Davide F Robbiani
December 2020, Stem cell research,
Filippo Bianchini, and Virginia Crivelli, and Morgan E Abernathy, and Concetta Guerra, and Martin Palus, and Jonathan Muri, and Harold Marcotte, and Antonio Piralla, and Mattia Pedotti, and Raoul De Gasparo, and Luca Simonelli, and Milos Matkovic, and Chiara Toscano, and Maira Biggiogero, and Veronica Calvaruso, and Pavel Svoboda, and Tomás Cervantes Rincón, and Tommaso Fava, and Lucie Podešvová, and Akanksha A Shanbhag, and Andrea Celoria, and Jacopo Sgrignani, and Michal Stefanik, and Vaclav Hönig, and Veronika Pranclova, and Tereza Michalcikova, and Jan Prochazka, and Giuditta Guerrini, and Dora Mehn, and Annalisa Ciabattini, and Hassan Abolhassani, and David Jarrossay, and Mariagrazia Uguccioni, and Donata Medaglini, and Qiang Pan-Hammarström, and Luigi Calzolai, and Daniel Fernandez, and Fausto Baldanti, and Alessandra Franzetti-Pellanda, and Christian Garzoni, and Radislav Sedlacek, and Daniel Ruzek, and Luca Varani, and Andrea Cavalli, and Christopher O Barnes, and Davide F Robbiani
January 2021, mAbs,
Filippo Bianchini, and Virginia Crivelli, and Morgan E Abernathy, and Concetta Guerra, and Martin Palus, and Jonathan Muri, and Harold Marcotte, and Antonio Piralla, and Mattia Pedotti, and Raoul De Gasparo, and Luca Simonelli, and Milos Matkovic, and Chiara Toscano, and Maira Biggiogero, and Veronica Calvaruso, and Pavel Svoboda, and Tomás Cervantes Rincón, and Tommaso Fava, and Lucie Podešvová, and Akanksha A Shanbhag, and Andrea Celoria, and Jacopo Sgrignani, and Michal Stefanik, and Vaclav Hönig, and Veronika Pranclova, and Tereza Michalcikova, and Jan Prochazka, and Giuditta Guerrini, and Dora Mehn, and Annalisa Ciabattini, and Hassan Abolhassani, and David Jarrossay, and Mariagrazia Uguccioni, and Donata Medaglini, and Qiang Pan-Hammarström, and Luigi Calzolai, and Daniel Fernandez, and Fausto Baldanti, and Alessandra Franzetti-Pellanda, and Christian Garzoni, and Radislav Sedlacek, and Daniel Ruzek, and Luca Varani, and Andrea Cavalli, and Christopher O Barnes, and Davide F Robbiani
August 2020, Nature communications,
Filippo Bianchini, and Virginia Crivelli, and Morgan E Abernathy, and Concetta Guerra, and Martin Palus, and Jonathan Muri, and Harold Marcotte, and Antonio Piralla, and Mattia Pedotti, and Raoul De Gasparo, and Luca Simonelli, and Milos Matkovic, and Chiara Toscano, and Maira Biggiogero, and Veronica Calvaruso, and Pavel Svoboda, and Tomás Cervantes Rincón, and Tommaso Fava, and Lucie Podešvová, and Akanksha A Shanbhag, and Andrea Celoria, and Jacopo Sgrignani, and Michal Stefanik, and Vaclav Hönig, and Veronika Pranclova, and Tereza Michalcikova, and Jan Prochazka, and Giuditta Guerrini, and Dora Mehn, and Annalisa Ciabattini, and Hassan Abolhassani, and David Jarrossay, and Mariagrazia Uguccioni, and Donata Medaglini, and Qiang Pan-Hammarström, and Luigi Calzolai, and Daniel Fernandez, and Fausto Baldanti, and Alessandra Franzetti-Pellanda, and Christian Garzoni, and Radislav Sedlacek, and Daniel Ruzek, and Luca Varani, and Andrea Cavalli, and Christopher O Barnes, and Davide F Robbiani
January 2023, Frontiers in molecular neuroscience,
Filippo Bianchini, and Virginia Crivelli, and Morgan E Abernathy, and Concetta Guerra, and Martin Palus, and Jonathan Muri, and Harold Marcotte, and Antonio Piralla, and Mattia Pedotti, and Raoul De Gasparo, and Luca Simonelli, and Milos Matkovic, and Chiara Toscano, and Maira Biggiogero, and Veronica Calvaruso, and Pavel Svoboda, and Tomás Cervantes Rincón, and Tommaso Fava, and Lucie Podešvová, and Akanksha A Shanbhag, and Andrea Celoria, and Jacopo Sgrignani, and Michal Stefanik, and Vaclav Hönig, and Veronika Pranclova, and Tereza Michalcikova, and Jan Prochazka, and Giuditta Guerrini, and Dora Mehn, and Annalisa Ciabattini, and Hassan Abolhassani, and David Jarrossay, and Mariagrazia Uguccioni, and Donata Medaglini, and Qiang Pan-Hammarström, and Luigi Calzolai, and Daniel Fernandez, and Fausto Baldanti, and Alessandra Franzetti-Pellanda, and Christian Garzoni, and Radislav Sedlacek, and Daniel Ruzek, and Luca Varani, and Andrea Cavalli, and Christopher O Barnes, and Davide F Robbiani
May 2020, Cellular & molecular immunology,
Copied contents to your clipboard!